Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009600:Nitroquinolines / Q000627:therapeutic use*; D010073:Oxamniquine / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D012550:Schistosoma mansoni / Q000187:drug effects; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000627:therapeutic use*
D009600:Nitroquinolines; D010919:Placebos; D012556:Schistosomicides; D010073:Oxamniquine